Myosin Modulators: The New Era of Medical Therapy for Systolic Heart Failure and Hypertrophic Cardiomyopathy

A new uprising pharmacological treatment for systolic heart failure and hypertrophic cardiomyopathy demonstrates very promising results the last years. Myosin modulators have already been tested in numerous studies. Myosin inhibitor (mavacamten) and myosin stimulator, (omecamtiv mecarbil) exhibit th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lekaditi, Dimitra, Sakellaropoulos, Stefanos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139755/
https://www.ncbi.nlm.nih.gov/pubmed/34046107
http://dx.doi.org/10.14740/cr1243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139755/
https://www.ncbi.nlm.nih.gov/pubmed/34046107
http://dx.doi.org/10.14740/cr1243

Ejemplares similares